Core Viewpoint - Rosen Law Firm is reminding investors who purchased Synopsys, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Synopsys securities between December 4, 2024, and September 9, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 30, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The lawsuit alleges that Synopsys made materially false and misleading statements and failed to disclose adverse facts about its business and operations during the Class Period [5]. - Specific claims include that Synopsys' focus on artificial intelligence customers negatively impacted the economics of its Design IP business and that certain strategic decisions were unlikely to yield intended results [5]. - The lawsuit asserts that these undisclosed issues had a materially negative impact on Synopsys' financial results, leading to investor damages when the true information became public [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Molina Healthcare, Inc. to secure legal counsel before the December 2, 2025 deadline for a securities class action lawsuit related to undisclosed adverse facts affecting the company's financial guidance and operations [2][6]. Group 1: Class Action Details - The class action pertains to Molina securities purchased between February 5, 2025, and July 23, 2025, with a lead plaintiff deadline set for December 2, 2025 [2][4]. - Investors who purchased Molina securities during the class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. Group 2: Allegations Against Molina - The lawsuit alleges that Molina failed to disclose material adverse facts regarding its medical cost trend assumptions and the dislocation between premium rates and medical costs [6]. - It is claimed that Molina's near-term growth relied on a lack of utilization of various health services, which could lead to a substantial cut in the company's financial guidance for fiscal year 2025 [6]. - The lawsuit asserts that positive statements made by Molina regarding its business and prospects were materially misleading and lacked a reasonable basis [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [5]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5].

Core Insights - Altima Energy Inc. is currently finalizing its audited annual financial statements and related disclosures, facing delays due to technical issues with new reporting software [1] - The company produced a total of 6,359.19 BOE (1,012.79 m³) in October, with 82.9% being oil, and plans to enhance production through a winter workover program [2] Financial Status Update - The completion of the audited financial statements for the year ended February 28, 2025, and subsequent quarters is ongoing, with significant progress reported despite delays [1] - A cease trade order remains in effect, and the company's securities are suspended by the TSX Venture Exchange until the financial statements are filed [1] Production Results - In October, Altima Energy's production included assets from Red Earth, Richdale, and Chambers Ferrier fields, with a focus on increasing output through planned workover programs [2] Company Overview - Altima Energy is an oil and gas exploration and production company based in Vancouver, focusing on hydrocarbon asset development across North America [3] - The company emphasizes efficient resource development and operational excellence to drive sustainable growth and long-term value creation for shareholders [3]

Core Points - 37 Capital Inc. has closed the third tranche of equity financing, raising total gross proceeds of $90,625 by issuing 725,000 units at a price of $0.125 per unit [1] - Each unit consists of one common share and one share purchase warrant, allowing the purchase of one common share at $0.15 for three years [1] - The financing proceeds will be utilized for general working capital [2] Financing Details - A finder's fee of $6,344 was paid in cash, along with the issuance of 50,750 finder's warrants exercisable at $0.15 per share for two years [2] - All securities issued are subject to a hold period expiring on March 21, 2026 [2] Incentive Stock Options - The Company granted 400,000 incentive stock options to an insider, exercisable at $0.155 per common share for three years [3] - These options are reserved under the Company's 20% Rolling Stock Option Plan and are subject to a vesting period [3] - Shares issued from the exercise of these options will also be subject to a hold period expiring on March 21, 2026 [3]

Core Viewpoint - Rosen Law Firm is encouraging investors of James Hardie Industries plc to seek legal counsel regarding a securities class action lawsuit due to misleading information about the company's performance during a specific period [2][6]. Group 1: Class Action Details - The class action pertains to investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, with a lead plaintiff deadline set for December 23, 2025 [2][4]. - The lawsuit alleges that James Hardie misled investors about the strength of its North America Fiber Cement segment, falsely claiming that demand was strong while distributors were actually destocking inventory [6]. Group 2: Legal Representation - Investors are advised to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions for investors [5].

Core Viewpoint - Rosen Law Firm is encouraging investors of Inspire Medical Systems, Inc. to secure legal counsel before the January 5, 2026 deadline for a securities class action lawsuit related to the company's stock performance during the specified class period [2][4]. Group 1: Class Action Details - The class period for the lawsuit is from August 6, 2024, to August 4, 2025, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6]. - A class action lawsuit has already been filed, and investors wishing to serve as lead plaintiffs must act by January 5, 2026 [4][8]. Group 2: Allegations Against Inspire Medical - The lawsuit alleges that Inspire Medical misrepresented and failed to disclose critical information regarding the Inspire V sleep apnea device, including its actual market demand and the necessary steps for its launch [6]. - Defendants are accused of issuing materially false and misleading statements that led investors to believe in strong demand for the Inspire V device, resulting in investor damages when the true situation was revealed [6]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [5]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5].

Core Viewpoint - Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Freeport-McMoRan Inc. securities between February 15, 2022, and September 24, 2025, alleging misleading statements and safety issues at the Grasberg Block Cave mine in Indonesia [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Freeport-McMoRan failed to ensure adequate safety at its Grasberg Block Cave mine, leading to heightened risks for workers and potential regulatory and reputational consequences [5]. - Investors who purchased securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [3][6]. - A lead plaintiff must be appointed by January 12, 2026, to represent the class in the litigation [1][3]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013 [4].

Core Insights - Sailfish Royalty Corp. reported strong financial results for Q3 2025, with significant increases in revenues and net income compared to the same period in 2024 [2][3][4]. Financial Performance - Revenues for Q3 2025 reached $879,473, up from $730,024 in Q3 2024, representing a 20.4% increase [3]. - Gross profit for Q3 2025 was $764,206, compared to $454,040 in Q3 2024, marking a 68.2% increase [3]. - The company achieved a net income of $1,724,494 in Q3 2025, a significant turnaround from a net loss of $137,648 in Q3 2024 [3][8]. - Basic loss per share improved to $0.02 in Q3 2025 from a loss of $0.00 in Q3 2024 [3]. Year-to-Date Performance - For the nine months ended September 30, 2025, total revenues were $2,179,871, slightly up from $2,114,221 in the same period of 2024 [3]. - Gross profit for the nine months was $2,014,024, compared to $1,267,809 in the previous year, reflecting a 58.6% increase [3]. - Net income for the nine months was $1,834,093, compared to $1,151,857 in the same period of 2024 [3][8]. Royalty and Stream Interests - Royalty revenue for Q3 2025 was $430,334, up from $211,942 in Q3 2024 [8]. - Gold ounces earned from stream interests were 25 for Q3 2025, down from 215 in Q3 2024, while silver ounces earned were 9,329, compared to none in Q3 2024 [8]. - The company entered into a binding term sheet with Mako Mining Corp. for a five-year gold stream and a 2% NSR royalty on the Mt. Hamilton Gold-Silver Project in Nevada [8]. Shareholder Returns - The company declared a dividend of $0.0125 per common share, resulting in a cash payment of $633,053 and the issuance of 310,034 common shares under the dividend reinvestment plan [6][8]. - A total of 631,100 common shares were repurchased for cancellation under the normal course issuer bid for the nine months ended September 30, 2025 [8].

Group 1 - Rise Gold Corp. has appointed Mr. David Watkinson as President and CEO, along with his role as President of the wholly owned subsidiary, Rise Grass Valley Inc. [1] - The Annual General Meeting held on November 19, 2025, resulted in the passing of all resolutions, including the re-appointment of Davidson & Company LLP as auditor and the approval of the Corporation's long-term incentive plan [1] - Daniel Oliver has been appointed as Chairman of the Board [1] Group 2 - Mr. Watkinson has over 40 years of engineering experience in mine development and has held senior positions in notable companies such as Placer Dome Inc. and Kinross Gold Corporation [2] - He was previously the President and CEO of Emgold Mining Corporation, which controlled the Idaho-Maryland mine for approximately 25 years [2] Group 3 - Dan Oliver expressed confidence in Mr. Watkinson's leadership to unlock the value of the Idaho-Maryland Mine, which produced an estimated 2.4 million ounces of gold from 1862 to 1957 [3] - The mine operated with an average mill head grade of 0.50 ounces per ton (17.1 grams per tonne) and produced tungsten with support from the Department of Defense from 1955 to 1957 [3] - The company filed a writ of mandamus against Nevada County regarding its right to operate the I-M Mine, with a verdict expected in the first quarter of 2026 [3] Group 4 - Mr. Joe Mullin has resigned from his positions as President and CEO and as a member of the Board of Directors to pursue a new opportunity [4] - The company has granted 2,660,000 stock options to directors, officers, and consultants, exercisable at a price of US$0.18 per share until November 20, 2030 [4]

Core Viewpoint - Focus Graphite Inc. has announced a bought deal offering of 8,333,400 units at a price of $0.42 per unit, aiming to raise approximately $3.5 million in gross proceeds [1][3]. Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant allowing the purchase of an additional common share at $0.60 for 30 months post-closing [2]. - The offering is expected to close around the week of December 8, 2025, pending necessary regulatory approvals [7]. Use of Proceeds - The net proceeds from the offering will be allocated for temporary working capital, payments related to the Government of Canada's Global Partnership Initiative, and general corporate purposes [3]. Underwriter Information - Research Capital Corporation is the sole underwriter and has an option to increase the offering size by up to 15% [4]. - The underwriter will receive a cash commission of 7.0% of the gross proceeds and broker warrants equivalent to 7.0% of the units sold [8]. Regulatory Compliance - The units will be offered under the listed issuer financing exemption in all provinces of Canada, except Quebec, and in other qualifying jurisdictions, including the United States [5].